GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 4.250-4.350 for the period, compared to the consensus EPS estimate of 4.280. The company issued revenue guidance of -.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the stock. Stifel Nicolaus boosted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. Evercore ISI lifted their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a "neutral" rating and a $90.00 price target for the company. Finally, UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and cut their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. One research analyst has rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average price target of $95.46.
Check Out Our Latest Stock Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Up 0.4 %
GEHC traded up $0.34 during trading on Thursday, reaching $77.43. 3,383,933 shares of the stock were exchanged, compared to its average volume of 3,056,494. The stock has a market cap of $35.38 billion, a P/E ratio of 21.27, a price-to-earnings-growth ratio of 2.96 and a beta of 1.07. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock's 50 day moving average price is $85.14 and its two-hundred day moving average price is $83.75. GE HealthCare Technologies has a twelve month low of $71.31 and a twelve month high of $94.55.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to analysts' expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies's quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.99 EPS. Equities analysts expect that GE HealthCare Technologies will post 4.3 EPS for the current year.
GE HealthCare Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.18%. GE HealthCare Technologies's payout ratio is presently 3.85%.
Insider Buying and Selling at GE HealthCare Technologies
In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.27% of the company's stock.
About GE HealthCare Technologies
(
Get Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
